|Title:||Zinc oxide nanoparticles-induced intercellular adhesion molecule 1 expression requires Rac1/Cdc42, mixed lineage kinase 3, and c-Jun N-terminal kinase activation in endothelial cells||Authors:||Li C
|Issue Date:||2012||Journal Volume:||126||Journal Issue:||1||Start page/Pages:||162-172||Source:||Toxicological Sciences||Abstract:||
The explosive development of nanotechnology has caused an increase in unintended biohazards in humans and in the ecosystem. Similar to particulate matter, nanoparticles (NPs) are strongly correlated with the increase in incidences of cardiovascular diseases, yet the mechanisms behind this correlation remain unclear. Within the testing concentrations of 0.1-10 μg/ml, which did not cause a marked drop in cell viability, zinc oxide NPs (ZnO-NPs) induced intercellular adhesion molecule-1 (ICAM-1) messenger RNA, and protein expression in both concentration- and time-dependent manner in treated human umbilical vein endothelial cells (HUVECs). ZnO-NPs treatment cause the activation of Ras-related C3 botulinum toxin substrate 1 (Rac1)/cell division control protein 42 homolog (Cdc42) and protein accumulation of mixed lineage kinase 3 (MLK3), followed by c-Jun N-terminal kinase (JNK) and transcription factor c-Jun activation. Induction of ICAM-1 and phosphorylation of JNK and c-Jun could be inhibited by either JNK inhibitor SP600125 or Rac guanosine triphosphatase inhibitor NSC23766 pretreatment. In addition, pretreatment with NSC23766 significantly reduced MLK3 accumulation, suggesting the involvement of Rac1/Cdc42-MLK3-JNK-c-Jun signaling in the regulation of ZnO-NPs-induced ICAM-1 expression, whereas these signaling factors were not activated in zinc oxide microparticles (ZnO-MPs)-treated HUVECs. The increase of ICAM-1 expression on ZnO-NPs-treated HUVECs enables leukocytes to adhere and has been identified as an indicator of vascular inflammation. Our data are essential for safety evaluation of the clinical usage of ZnO-NPs in daily supplements, cosmetics, and biomedicines. ? The Author 2011. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved.
|URI:||https://scholars.lib.ntu.edu.tw/handle/123456789/458803||ISSN:||1096-6080||DOI:||10.1093/toxsci/kfr331||SDG/Keyword:||4 amino 6 [2 [[4 (diethylamino) 1 methylbutyl]amino] 6 methyl 4 pyrimidinyl] 2 methylquinoline; anthra[1,9 cd]pyrazol 6(2h) one; intercellular adhesion molecule 1; messenger RNA; mixed lineage kinase 3; nanoparticle; protein Cdc42; Rac1 protein; stress activated protein kinase; unclassified drug; zinc oxide; zinc oxide nanoparticle; animal experiment; animal tissue; article; cell membrane permeability; concentration response; controlled study; enzyme inhibition; enzyme phosphorylation; gene expression regulation; gene induction; human; human cell; in vivo study; leukemia cell; leukocyte adherence; monocyte; mouse; nonhuman; particle size; protein content; protein expression; protein induction; protein localization; signal transduction; transcription initiation; umbilical vein endothelial cell
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.